Corpay Other Income (Expense) increased by 20.6% to -$131.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.7%, from -$99.61M to -$131.15M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 35.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$35.09M | -$30.57M | -$37.81M | -$23.05M | -$26.83M | -$49.27M | -$71.83M | -$80.35M | -$86.08M | -$74.88M | -$90.55M | -$92.05M | -$99.14M | -$109.85M | -$101.01M | -$99.61M | -$86.30M | -$101.42M | -$165.10M | -$131.15M |
| QoQ Change | — | +12.9% | -23.7% | +39.0% | -16.4% | -83.7% | -45.8% | -11.9% | -7.1% | +13.0% | -20.9% | -1.6% | -7.7% | -10.8% | +8.0% | +1.4% | +13.4% | -17.5% | -62.8% | +20.6% |
| YoY Change | — | — | — | — | +23.6% | -61.2% | -90.0% | -248.6% | -220.9% | -52.0% | -26.1% | -14.6% | -15.2% | -46.7% | -11.5% | -8.2% | +12.9% | +7.7% | -63.4% | -31.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Vehicle Payments | $5.00K | -$2.00K | -$11.19M | -$6.93M |
| Corporate Payments | $0.00 | $0.00 | -$6.00K | -$301.00K |
| Lodging Payments | $0.00 | $0.00 | -$3.00K | -$73.00K |
| Other | $0.00 | $0.00 | -$2.00K | -$48.00K |
| Total | -$99.61M | -$86.30M | -$101.42M | -$131.15M |